For complete details or to register, visit www.IN3Summit.com.
Flexible Pricing is Still Available – Call for Select Discounts!
+1-949-453-0071
The medtech industry’s leading conference for face-to-face dialogue with top investors, large device companies, and the hottest emerging innovators.
* Robust program with more than 30 investors & industry leaders scheduled to present.
* 35+ emerging innovators expected – Only 4 speaking slots remaining – Apply to Present now!
* “Medtech Risk Capital? Anything But. A VC Roundtable from IN3”
(Start-Up Magazine, Sept. 2010) DOWNLOAD THIS COMPLIMENTARY ARTICLE
* Download current event brochure + more.
At IN3 Summit, get all the latest news from these key sessions:
“What Are Corporate Buyers Looking For?”
* David Cassak, Vice President, Content, Elsevier Business Intelligence (moderator)
* Jeffrey J. Steinle, Sr. Director, Corporate Development, Medtronic
* Lukas Scheibler, PhD, Vice President, R & D Alliances, Alcon Laboratories, Inc.
“What Are the Hot Deals Now and in the Future?”
* David Cassak, Vice President, Content, Elsevier Business Intelligence (moderator)
* John Onopchenko, Managing Director, Synergy LSP
* Jeani Delagardelle, Managing Director, New Leaf Ventures
* Evan Melrose, Managing Director, PTV Sciences
* Lisa Suennen, Co-founder and Managing Member, Psilos
* Teo Forcht Dagi, MD, MPH, Partner, HLM Venture Partners
“Changes to the 510(k) Program: New Requirements You Must Implement.”
* David Filmore, Senior Editor of “The Gray Sheet” (moderator) – Elsevier Business Intelligence
* Christy Foreman, Acting Director of the Office of Device Evaluation – CDRH, FDA
* Dr. Joshua Makower, Founder/CEO, ExploraMed, Inc.
* Laurie Clarke, Partner, King & Spaulding, LLP